Deep Track Capital »

Monopar Therapeutics shares owned by Deep Track Capital

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.2M 95k 65.30

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Immunovant (IMVT)
Guardant Health (GH)
Structure Therapeutics Sponsored Ads (GPCR)
Tarsus Pharmaceuticals (TARS)
Dynavax Technologies Corp Com New (DVAX)
Cytokinetics Com New (CYTK)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Vaxcyte (PCVX)
Maze Therapeatics (MAZE)
Vera Therapeutics Cl A (VERA)
BioMarin Pharmaceutical (BMRN)
Ionis Pharmaceuticals (IONS)
Nurix Therapeutics (NRIX)

View all positions for Deep Track Capital

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Saturn V Capital Management
Vanguard Group
BlackRock
ADAR1 Capital Management
Wellington Management Company
Siren
Deerfield Management Company
TCG Crossover Management
Polar Capital Holdings
Geode Capital Management
Deep Track Capital
Vivo Capital

View all funds holding Monopar Therapeutics